Effects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and Agonist-Induced contraction in rat resistance arteries

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Khurana, Sandeep ^a   Raina, Hema ^a   Pappas, Valeria ^b,c   Raufman, Jean Pierre ^a   Pallone, Thomas L ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Division of Nephrology   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ANGIOTENSIN II; ATROPINE; BILE ACID; CALCIUM ION; GLIBENCLAMIDE; GLYCODEOXYCHOLIC ACID; INDOMETACIN; MUSCARINIC RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY RESISTANCE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HEMODYNAMICS; MESENTERIC ARTERY; MUSCLE CONTRACTION; MUSCLE TONE; NONHUMAN; PRESSURE MEASUREMENT; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; SYSTEMIC VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASOMOTOR REFLEX; ANIMAL; DRUG EFFECT; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

ANIMALS; BILE ACIDS AND SALTS; GLYCODEOXYCHOLIC ACID; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84857134370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032006     Document Type: Article

References (47)

1. Staels B, Fonseca VA, (2009) Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 32 (Suppl 2): S237-245.
2. Khurana S, Raufman JP, Pallone TL, (2011) Bile acids regulate cardiovascular function. Clin Transl Sci 4: 210-218.
3. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, et al. (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem 278: 9435-9440.
4. Raufman JP, Chen Y, Zimniak P, Cheng K, (2002) Deoxycholic acid conjugates are muscarinic cholinergic receptor antagonists. Pharmacology 65: 215-221.
5. Raufman JP, Chen Y, Cheng K, Compadre C, Compadre L, et al. (2002) Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry. Eur J Pharmacol 457: 77-84.
6. Dopico AM, Walsh JV Jr, Singer JJ, (2002) Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells. J Gen Physiol 119: 251-273.
7. Sheikh Abdul Kadir SH, Miragoli M, Abu-Hayyeh S, Moshkov AV, Xie Q, et al. (2010) Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One 5: e9689.
8. Li J, Wilson A, Kuruba R, Zhang Q, Gao X, et al. (2008) FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 77: 169-177.
9. He F, Li J, Mu Y, Kuruba R, Ma Z, et al. (2006) Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 98: 192-199.
10. Zhang Q, He F, Kuruba R, Gao X, Wilson A, et al. (2008) FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc Res 77: 560-569.
11. Pak JM, Lee SS, (1993) Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies. Hepatology 18: 1175-1181.
12. Khurana S, Yamada M, Wess J, Kennedy RH, Raufman JP, (2005) Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. Eur J Pharmacol 517: 103-110.
13. Bukiya AN, Liu J, Toro L, Dopico AM, (2007) Beta1 (KCNMB1) subunits mediate lithocholate activation of large-conductance Ca2+-activated K+ channels and dilation in small, resistance-size arteries. Mol Pharmacol 72: 359-369.
14. Schubert R, Lidington D, Bolz SS, (2008) The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 77: 8-18.
15. Osborn JW, Fink GD, Kuroki MT, (2011) Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep 13: 221-228.
16. Sanyal AJ, Bosch J, Blei A, Arroyo V, (2008) Portal hypertension and its complications. Gastroenterology 134: 1715-1728.
17. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, et al. (2009) Bile acids as regulatory molecules. J Lipid Res 50: 1509-1520.
18. Raufman JP, Zimniak P, Bartoszko-Malik A, (1998) Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach. Am J Physiol 274: G997-1004.
19. Pazzi P, Morsiani E, Vilei MT, Granato A, Rozga J, et al. (2002) Serum bile acids in patients with liver failure supported with a bioartificial liver. Aliment Pharmacol Ther 16: 1547-1554.
20. Neale G, Lewis B, Weaver V, Panveliwalla D, (1971) Serum bile acids in liver disease. Gut 12: 145-152.
21. Kowalski HJ, Abelmann WH, (1953) The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 32: 1025-1033.
22. Glantz A, Marschall HU, Mattsson LA, (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40: 467-474.
23. Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH, (1996) Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol 11: 208-215.
24. Linnet K, (1983) Postprandial plasma concentrations of glycine and taurine conjugated bile acids in healthy subjects. Gut 24: 249-252.
25. Pak JM, Adeagbo AS, Triggle CR, Shaffer EA, Lee SS, (1994) Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle. Br J Pharmacol 112: 1209-1215.
26. Brophy CM, Knoepp L, Xin J, Pollock JS, (2000) Functional expression of NOS 1 in vascular smooth muscle. Am J Physiol Heart Circ Physiol 278: H991-997.
27. Hilgers RH, Todd J Jr, Webb RC, (2006) Regional heterogeneity in acetylcholine-induced relaxation in rat vascular bed: role of calcium-activated K+ channels. Am J Physiol Heart Circ Physiol 291: H216-222.
28. Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, et al. (2005) Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter. Circ Res 96: 216-224.
29. Goto K, Rummery NM, Grayson TH, Hill CE, (2004) Attenuation of conducted vasodilatation in rat mesenteric arteries during hypertension: role of inwardly rectifying potassium channels. J Physiol 561: 215-231.
30. Ploug KB, Baun M, Hay-Schmidt A, Olesen J, Jansen-Olesen I, (2010) Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues. Eur J Pharmacol 637: 109-117.
31. Zhang Z, Lin H, Cao C, Khurana S, Pallone TL, (2010) Voltage-gated divalent currents in descending vasa recta pericytes. Am J Physiol Renal Physiol 299: F862-871.
32. Hill MA, Zou H, Potocnik SJ, Meininger GA, Davis MJ, (2001) Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 91: 973-983.
33. Christensen KL, Mulvany MJ, (1993) Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 30: 73-79.
34. Fenger-Gron J, Mulvany MJ, Christensen KL, (1995) Mesenteric blood pressure profile of conscious, freely moving rats. J Physiol 488 (Pt 3): 753-760.
35. Koenigsberger M, Sauser R, Seppey D, Beny JL, Meister JJ, (2008) Calcium dynamics and vasomotion in arteries subject to isometric, isobaric, and isotonic conditions. Biophys J 95: 2728-2738.
36. Ohkubo H, Okuda K, Iida S, Ohnishi K, Ikawa S, et al. (1984) Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. Gastroenterology 86: 514-520.
37. Nakajima T, Okuda Y, Chisaki K, Shin WS, Iwasawa K, et al. (2000) Bile acids increase intracellular Ca(2+) concentration and nitric oxide production in vascular endothelial cells. Br J Pharmacol 130: 1457-1467.
38. Keitel V, Reinehr R, Gatsios P, Rupprecht C, Gorg B, et al. (2007) The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 45: 695-704.
39. Kutluay E, Roux B, Heginbotham L, (2005) Rapid intracellular TEA block of the KcsA potassium channel. Biophys J 88: 1018-1029.
40. Lenaeus MJ, Vamvouka M, Focia PJ, Gross A, (2005) Structural basis of TEA blockade in a model potassium channel. Nat Struct Mol Biol 12: 454-459.
41. Bishop-Bailey D, Walsh DT, Warner TD, (2004) Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci U S A 101: 3668-3673.
42. Hagedorn KA, Cooke CL, Falck JR, Mitchell BF, Davidge ST, (2007) Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor. Hypertension 49: 328-333.
43. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA, (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19: 1509-1519.
44. Fiorucci S, Mencarelli A, Palladino G, Cipriani S, (2009) Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 30: 570-580.
45. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, et al. (2008) Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 27: 3092-3103.
46. Song JG, Cao YF, Sun YM, Ge YH, Xu XW, et al. (2009) Baroreflex sensitivity is impaired in patients with obstructive jaundice. Anesthesiology 111: 561-565.
47. Raina H, Zhang Q, Rhee AY, Pallone TL, Wier WG, (2010) Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries. Am J Physiol Heart Circ Physiol 298: H2093-2101.